miR-30b-5p targets CD73 and inhibits gastric cancer migration and invasion via PTEN/AKT/GSK3β/mTOR pathway

Author:

Liu Hongli1,Guo Shuang1,Li Ya1,Lei Ting1,Chen Qian2

Affiliation:

1. Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University

2. Xi’an Jiaotong University Health Center

Abstract

Abstract Background and purpose: Gastric cancer (GC) is the fifth most common cancer and the third leading cause of cancer-related deaths worldwide. CD73 has been found to be overexpressed in a variety of cancers including GC and is associated with poor cancer prognosis. However, its specific mechanisms regulating the progression of GC are not sufficiently clear. In this study, we aimed to investigate the function of CD73 in GC and to explore its upstream and downstream molecular mechanisms. Methods: Immunohistochemistry (IHC) and western blotting were used to detect the protein levels of CD73 and other proteins. Quantitative real-time PCR (RT-qPCR) was used to detect the RNA levels of CD73, miR-30b-5p, and other genes. CCK-8 and clonogenic assays were used to test cell proliferation. Scracth and Transwell were used to analyze the migration and invasion of GC cells. In addition, CD73 stable knockdown and overexpression cell lines were established to detect the expression of PTEN/AKT/GSK3β/mTOR pathway-related molecules. Dual luciferase reporter assay was used to detect the binding of CD73 and miR-30b-5p. Results: We found that miR-30b-5p targeted binding and inhibited CD73 overexpression, and suppressed GC cell proliferation, migration and invasion in GC cells. We further revealed that these effects were mediated through the PTEN/AKT/GSK3β/mTOR signalling pathway. Conclusions: In summary, our results reveal the relevance of the miR-30b-5p/CD73/PTEN/AKT/GSK3β /mTOR regulatory axis to migration and invasion in gastric cancer.

Publisher

Research Square Platform LLC

Reference32 articles.

1. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology;Ajani JA;J Natl Compr Canc Netw,2022

2. Progress in the treatment of advanced gastric cancer;Song Z;Tumour Biol,2017

3. Medical management of gastric cancer: a2017 update;Charalampakis N;Cancer Med,2018

4. The Effects of CD73 on Gastrointestinal Cancer Progression and Treatment;Sun P;J Oncol,2022

5. Targeting CD73 to augment cancer immunotherapy;Roh M;Curr Opin Pharmacol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3